These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

745 related articles for article (PubMed ID: 28601382)

  • 21. Omission of axillary lymph node dissection for clinically node negative early-stage breast cancer patients.
    Kobayashi R; Shiraishi K; Iwase S; Ohtomo K; Nakagawa K
    Breast Cancer; 2015 Nov; 22(6):657-63. PubMed ID: 24756246
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of the axilla with sentinel lymph node biopsy after neoadjuvant chemotherapy for breast cancer: A single-center study.
    Aksoy SO; Sevinc Aİ; Ünal M; Balci P; Görkem İB; Durak MG; Ozer O; Bekiş R; Emir B
    Medicine (Baltimore); 2020 Dec; 99(49):e23538. PubMed ID: 33285770
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Eight-year follow up result of the OTOASOR trial: The Optimal Treatment Of the Axilla - Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: A randomized, single centre, phase III, non-inferiority trial.
    Sávolt Á; Péley G; Polgár C; Udvarhelyi N; Rubovszky G; Kovács E; Győrffy B; Kásler M; Mátrai Z
    Eur J Surg Oncol; 2017 Apr; 43(4):672-679. PubMed ID: 28139362
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Experience of sentinel node biopsy alone in early breast cancer without further axillary dissection in patients with negative sentinel node.
    Soni NK; Spillane AJ
    ANZ J Surg; 2005 May; 75(5):292-9. PubMed ID: 15932439
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ten-year report on axillary recurrence after negative sentinel node biopsy for breast cancer from the Swedish Multicentre Cohort Study.
    de Boniface J; Frisell J; Bergkvist L; Andersson Y;
    Br J Surg; 2017 Feb; 104(3):238-247. PubMed ID: 28052310
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The significance of sentinel lymph node micrometastasis in breast cancer: Comparing outcomes with and without axillary clearance.
    Youssef MMG; Cameron D; Pucher PH; Olsen S; Ferguson D
    Breast; 2016 Dec; 30():101-104. PubMed ID: 27668857
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sentinel lymph node biopsy examination for breast cancer patients with clinically negative axillary lymph nodes after neoadjuvant chemotherapy.
    Kinoshita T; Takasugi M; Iwamoto E; Akashi-Tanaka S; Fukutomi T; Terui S
    Am J Surg; 2006 Feb; 191(2):225-9. PubMed ID: 16442950
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Favorable outcome with sentinel lymph node biopsy alone after neoadjuvant chemotherapy in clinically node positive breast cancer at diagnosis: Turkish Multicentric NEOSENTI-TURK MF-18-02-study.
    Cabıoğlu N; Karanlık H; Yıldırım N; Müslümanoğlu M; Çakmak Karadeniz G; Trabulus Can D; Tükenmez M; Ersoy YE; Uras C; Zengel B; Emiroğlu S; Polat AK; Yeniay L; Özkurt E; Kara H; İbiş K; Aydıner A; Özmen V; İğci A
    Eur J Surg Oncol; 2021 Oct; 47(10):2506-2514. PubMed ID: 34217580
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sentinel lymph node mapping following neoadjuvant chemotherapy for breast cancer.
    Brady EW
    Breast J; 2002; 8(2):97-100. PubMed ID: 11896755
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical usefulness and perspectives of sentinel node biopsy in the management of breast cancer].
    Haid A; Koeberle-Wuehrer R; Offner F; Jasarevic Z; Fritzsche H; Zimmermann G
    Chirurg; 2003 Jul; 74(7):657-64. PubMed ID: 12883794
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of sentinel lymph node biopsy by ultrasound-guided core needle biopsy for patients with suspicious node positive breast cancer.
    Nakamura R; Yamamoto N; Miyaki T; Itami M; Shina N; Ohtsuka M
    Breast Cancer; 2018 Jan; 25(1):86-93. PubMed ID: 28735457
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sentinel node biopsy in breast cancer patients treated with neoadjuvant chemotherapy.
    Tanaka Y; Maeda H; Ogawa Y; Nishioka A; Itoh S; Kubota K; Ue H; Nakatani K; Sasaguri S
    Oncol Rep; 2006 Apr; 15(4):927-31. PubMed ID: 16525681
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The feasibility and the role of sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer].
    Péley G; Török K; Farkas E; Mátrai Z; Horváth Z; Sinkovics I; Hitre E; Rényi-Vámos F; Orosz Z; Köves I
    Magy Onkol; 2006; 50(1):19-23. PubMed ID: 16617379
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of Radiation on Locoregional Control in Women with Node-Positive Breast Cancer Treated with Neoadjuvant Chemotherapy and Axillary Lymph Node Dissection: Results from ACOSOG Z1071 Clinical Trial.
    Haffty BG; McCall LM; Ballman KV; Buchholz TA; Hunt KK; Boughey JC
    Int J Radiat Oncol Biol Phys; 2019 Sep; 105(1):174-182. PubMed ID: 31085287
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term prognoses and outcomes of axillary lymph node recurrence in 2,578 sentinel lymph node-negative patients for whom axillary lymph node dissection was omitted: results from one Japanese hospital.
    Ogiya A; Kimura K; Nakashima E; Sakai T; Miyagi Y; Iijima K; Morizono H; Makita M; Horii R; Akiyama F; Iwase T
    Breast Cancer; 2016 Mar; 23(2):318-22. PubMed ID: 25376341
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial].
    Sávolt A; Musonda P; Mátrai Z; Polgár C; Rényi-Vámos F; Rubovszky G; Kovács E; Sinkovics I; Udvarhelyi N; Török K; Kásler M; Péley G
    Orv Hetil; 2013 Dec; 154(49):1934-42. PubMed ID: 24292111
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The predictive value of sentinel lymph node biopsy in locally advanced breast cancer patients who have undergone neoadjuvant chemotherapy.
    Yamamoto M; Mehta RS; Baick CH; Su MY; Lane KT; Butler JA; Hsiang DJ
    Am Surg; 2007 Oct; 73(10):977-80. PubMed ID: 17983061
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sentinel lymph node biopsy after neoadjuvant chemotherapy for breast cancer: retrospective comparative evaluation of clinically axillary lymph node positive and negative patients, including those with axillary lymph node metastases confirmed by fine needle aspiration.
    Yu Y; Cui N; Li HY; Wu YM; Xu L; Fang M; Sheng Y
    BMC Cancer; 2016 Oct; 16(1):808. PubMed ID: 27756234
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A prospective feasibility study of sentinel node biopsy by modified Indigocarmine blue dye methods after neoadjuvant chemotherapy for breast cancer.
    Kida K; Ishikawa T; Yamada A; Shimizu D; Tanabe M; Sasaki T; Ichikawa Y; Endo I
    Eur J Surg Oncol; 2015 Apr; 41(4):566-70. PubMed ID: 25650249
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Feasibility of sentinel node biopsy for breast cancer after neoadjuvant endocrine therapy: a pilot study.
    Aihara T; Munakata S; Morino H; Takatsuka Y
    J Surg Oncol; 2004 Feb; 85(2):77-81. PubMed ID: 14755507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.